Jianke snags $130 mln Series B

Jianke, a Chinese online B2C pharmacy and healthcare services platform, has raised $130 million in Series B funding. GTJA Investment Group led the round with participation from HBM Healthcare Investments and Crescent Point.

ByIris Dorbian

4 September 2018•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Managers North America US Healthcare Briefs

Jianke snags $130 mln Series B

HBM Healthcare Investments

Shenzhen GTJA Investment Group (GIG)